Literature DB >> 9593114

Semiparametric estimation of major gene effects for age of onset.

H Li1, E A Thompson, E M Wijsman.   

Abstract

Analysis of age of onset is a key factor in the segregation and linkage analysis of some complex genetic traits. Previous work in the genetics literature has used parametric distributional assumptions on age of onset. In this paper, a Cox model with latent major gene effects is used: a semiparametric model with unspecified baseline hazard. A Monte Carlo EM procedure is used to obtain maximum likelihood estimates. Markov chain Monte Carlo is used to realize genotypic configurations from the posterior distribution given the current model and the observed data, and these genotypic configurations are used to estimate the expectations in the EM algorithm. Simulated data sets indicate that the parameters can be estimated well, and one real data set shows the practical applicability of the proposed method.

Entities:  

Mesh:

Year:  1998        PMID: 9593114     DOI: 10.1002/(SICI)1098-2272(1998)15:3<279::AID-GEPI6>3.0.CO;2-#

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  4 in total

1.  An additive genetic gamma frailty model for linkage analysis of diseases with variable age of onset using nuclear families.

Authors:  Hongzhe Li
Journal:  Lifetime Data Anal       Date:  2002-12       Impact factor: 1.588

2.  Proportional hazards models with discrete frailty.

Authors:  Chrys Caroni; Martin Crowder; Alan Kimber
Journal:  Lifetime Data Anal       Date:  2010-01-29       Impact factor: 1.588

3.  On proportional hazards assumption under the random effects models.

Authors:  Ronghui Xu; Anthony Gamst
Journal:  Lifetime Data Anal       Date:  2007-07-19       Impact factor: 1.588

4.  Non-parametric frailty Cox models for hierarchical time-to-event data.

Authors:  Francesca Gasperoni; Francesca Ieva; Anna Maria Paganoni; Christopher H Jackson; Linda Sharples
Journal:  Biostatistics       Date:  2020-07-01       Impact factor: 5.899

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.